<code id='503864E868'></code><style id='503864E868'></style>
    • <acronym id='503864E868'></acronym>
      <center id='503864E868'><center id='503864E868'><tfoot id='503864E868'></tfoot></center><abbr id='503864E868'><dir id='503864E868'><tfoot id='503864E868'></tfoot><noframes id='503864E868'>

    • <optgroup id='503864E868'><strike id='503864E868'><sup id='503864E868'></sup></strike><code id='503864E868'></code></optgroup>
        1. <b id='503864E868'><label id='503864E868'><select id='503864E868'><dt id='503864E868'><span id='503864E868'></span></dt></select></label></b><u id='503864E868'></u>
          <i id='503864E868'><strike id='503864E868'><tt id='503864E868'><pre id='503864E868'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:641
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          New safety details link Apellis eye drug to rare cases of blindness
          New safety details link Apellis eye drug to rare cases of blindness

          AdobeFiveelderlypeoplehavebeenblindedinoneeyebyaseveresideeffectafterreceivinginjectionsofanewlyappr

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          NIH launches clinical trials and new research office for long Covid

          TheonlytrialunderwayrightnowwilltestwhetheralongerregimenofPfizer’santiviralPaxlovidalleviatessympto